These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 7808503)

  • 1. Deferoxamine in thalassemia major.
    Cazzola M; Locatelli F; De Stefano P
    N Engl J Med; 1995 Jan; 332(4):271-2; author reply 272-3. PubMed ID: 7808503
    [No Abstract]   [Full Text] [Related]  

  • 2. Deferoxamine treatment during early pregnancy: absence of teratogenicity in two cases.
    Vaskaridou E; Konstantopoulos K; Kyriakou D; Loukopoulos D
    Haematologica; 1993; 78(3):183-4. PubMed ID: 8375749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-transferrin-bound iron during blood transfusion cycles in beta-thalassemia major.
    Grosse R; Lund U; Caruso V; Fischer R; Janka GE; Magnano C; Engelhardt R; Dürken M; Nielsen P
    Ann N Y Acad Sci; 2005; 1054():429-32. PubMed ID: 16339692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deferoxamine in thalassemia major.
    Splendiani G; Tozzo C; Mazzarella V; Casciani CU
    N Engl J Med; 1995 Jan; 332(4):270-1. PubMed ID: 7808501
    [No Abstract]   [Full Text] [Related]  

  • 5. Deferoxamine in thalassemia major.
    Lucarelli G; Clift R; Angelucci E
    N Engl J Med; 1995 Jan; 332(4):271; author reply 272-3. PubMed ID: 7808502
    [No Abstract]   [Full Text] [Related]  

  • 6. Exchange blood transfusions for the treatment of leg ulcerations in thalassemia intermedia.
    Aessopos A; Kati M; Tsironi M; Polonifi E; Farmakis D
    Haematologica; 2006 May; 91(5 Suppl):ECR11. PubMed ID: 16709519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term intravenous deferoxamine treatment for noncompliant transfusion-dependent beta-thalassemia patients.
    Tamary H; Goshen J; Carmi D; Yaniv I; Kaplinsky C; Cohen IJ; Zaizov R
    Isr J Med Sci; 1994 Aug; 30(8):658-64. PubMed ID: 8045754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desferrioxamine induced urinary iron excretion in thalassemia.
    Dubey AP; Kumar S; Choudhury P; Talukdar B; Puri RK
    Indian Pediatr; 1993 Jun; 30(6):775-8. PubMed ID: 8132258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current trends in management of the beta thalassemias.
    Shah D; Choudhury P; Dubey AP
    Indian Pediatr; 1999 Dec; 36(12):1229-42. PubMed ID: 10745364
    [No Abstract]   [Full Text] [Related]  

  • 10. Desferrioxamine therapy induces clearance of iron deposits after bone marrow transplantation for thalassemia: case report.
    Giardini C; La Nasa G; Contu L; Galimberti M; Polchi P; Angelucci E; Baronciani D; Barbanti I; Muretto P; Lucarelli G
    Bone Marrow Transplant; 1993; 12 Suppl 1():108-10. PubMed ID: 8374548
    [No Abstract]   [Full Text] [Related]  

  • 11. [Measurement of the secretion of growth hormone in patients with thalassemia major].
    De Luca G; Maggiolini M; Bria M; Caracciolo M; Lanzino M; Le Pera M; Brancati C; Andò S
    Minerva Endocrinol; 1993 Sep; 18(3 Suppl 1):62-5. PubMed ID: 7910656
    [No Abstract]   [Full Text] [Related]  

  • 12. Glucose tolerance and beta-cell secretion in patients with thalassaemia major.
    Mangiagli A; Italia S; Campisi S
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():985-6. PubMed ID: 10091179
    [No Abstract]   [Full Text] [Related]  

  • 13. Sensory neural hearing loss in beta-thalassemia major patients treated with deferoxamine.
    Shamsian BS; Aminasnafi A; Moghadassian H; Gachkar L; Arzanian MT; Alavi S; Esfehani H; Garallahi F; Amini R
    Pediatr Hematol Oncol; 2008 Sep; 25(6):502-8. PubMed ID: 18728969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeuetic management of patients with thalassemia major].
    Thuret I
    Bull Soc Pathol Exot; 2001 May; 94(2):95-7. PubMed ID: 11475036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common queries in thalassemia care.
    Panigrahi I; Marwaha RK
    Indian Pediatr; 2006 Jun; 43(6):513-8. PubMed ID: 16820660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion-dependent beta thalassemia in Afghanistan: current evidence amid COVID-19 and future recommendations.
    Qaderi S; Mousavi SH; Ahmadi A; Arif S; Madadi S; Ayoubi S; Lucero-Prisno DE
    Hematology; 2021 Dec; 26(1):432-434. PubMed ID: 34130618
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiac status in well-treated patients with thalassemia major.
    Aessopos A; Farmakis D; Hatziliami A; Fragodimitri C; Karabatsos F; Joussef J; Mitilineou E; Diamanti-Kandaraki E; Meletis J; Karagiorga M
    Eur J Haematol; 2004 Nov; 73(5):359-66. PubMed ID: 15458515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy and lactation in homozygous beta-thalassemia major.
    Surbek DV; Glanzmann R; Nars PW; Holzgreve W
    J Perinat Med; 1998; 26(3):240-3. PubMed ID: 9773387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of thalassemia treated with conventional therapy.
    Borgna-Pignatti C; Zurlo MG; DeStefano P; Boffa C; DeSanctis V; DiPalma A; DiGregorio L; Melevendi C; Piga A; Sabato V
    Bone Marrow Transplant; 1993; 12 Suppl 1():2-4. PubMed ID: 8374554
    [No Abstract]   [Full Text] [Related]  

  • 20. Methods for noninvasive measurement of tissue iron in Cooley's anemia.
    Sheth S; Tang H; Jensen JH; Altmann K; Prakash A; Printz BF; Hordof AJ; Tosti CL; Azabagic A; Swaminathan S; Brown TR; Olivieri NF; Brittenham GM
    Ann N Y Acad Sci; 2005; 1054():358-72. PubMed ID: 16339684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.